Two moves mark Spain's new medical technology drive
This article was originally published in Clinica
Spain has approved E15m ($20m) to fund the launch of a national health technology assessment (HTA) programme, within a week of passing a law that regulates the creation and operational standards of a planned network of ultra-high-tech healthcare reference centres.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.